Stories of Interest in 2012
As we bring 2012 to a close, we're looking back at a few of the interesting events that took place. It was a challenge to whittle this down to a…
Menu
Radio Silence: Three Reasons Why It Happens in BD
Consider the following situation: You are out-licensing an innovative asset in a niche therapeutic area It is a first-in-class molecule It has successfully demonstrated efficacy in two international Phase…
Sandoz closes generic development center in India
Last week, Sandoz announced they are closing a number of generic product development centers around the world, including the Sandoz Development Centre near Mumbai. A few items in this report…
The Decline and Fall of The Monitor Empire
While we were recovering from our turkey-induced slumbers, we read the shocking news that Michael Porter's Monitor Group has filed for bankruptcy, and is being acquired by Delloitte . The…
Biosimilars: Three things you need to know
We've had the good fortune to work with a biosimilars client this year. Working in this space has given us an opportunity to read and listen to many experts in…
Geographic Diversity at BIO Europe 2012
As we've done in the past, we've tabulated the countries of origin from the stack of business card collected at BIO Europe 2012. Our "rules" for this analysis are simple.…
BIOEurope 2012: Does size matter?
We’ve returned from BIO Europe 2012 in Hamburg with a stack of business cards, pages of meeting notes, prioritized follow ups, and some great memories. We managed to completely fill…
What is innovation?
Bruce Booth (yet again) published a terrific post on his blog, entitled "NextWave of Pharma Innovation?" His premise is that reformulations, like the once-daily liquid methylphenidate product, Quillivant XR, is not…
Repositioned Drugs Surpass New Brands
There are some very interesting data published yesterday on FDA approval statistics: It was in 1984 when FDA first added the 505(b)(2) pathway for drug approval, a hybrid between the…
Observations from AAPS in Chicago
We spent a few days in Chicago attending the AAPS Convention. As usual, it was jammed with excellent science, tons of exhibitors, and great opportunities to catch up with old…
- Go to the previous page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- …
- 32
- Go to the next page